ARTIRIA Medical: Funding, Investors & Team (Sep 2026)
ARTIRIA Medical provides micro-actuated device allowing to treat vascular diseases.
ARTIRIA Medical has raised $4.2M across 2 funding rounds on record, the most recent a Convertible Note of $1.2M announced in Apr 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ARTIRIA Medical Company Profile and Key Stats
Latest funding round on record: Apr 2022.
ARTIRIA Medical Funding Rounds
ARTIRIA Medical raised $3.0M in an undisclosed round announced in Jul 2020.
1.8 years later, a Convertible Note of $1.2M was announced in Apr 2022.
ARTIRIA Medical Founders and Leadership Team
No contact details are on record for this team yet.
ARTIRIA Medical Funding Compared to Other Biotechnology Startups
ARTIRIA Medical's latest round of $1.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ARTIRIA Medical in Biotechnology and Lausanne
Companies Similar to ARTIRIA Medical
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
ARTIRIA Medical Funding FAQs
What does ARTIRIA Medical do?
ARTIRIA Medical provides micro-actuated device allowing to treat vascular diseases.
How much funding has ARTIRIA Medical raised?
ARTIRIA Medical has raised $4.2M across 2 rounds on record. The most recent is a Convertible Note of $1.2M announced in Apr 2022.
When did ARTIRIA Medical last raise funding?
ARTIRIA Medical's most recent funding round on record is a Convertible Note of $1.2M, announced in Apr 2022.
Who is the CEO of ARTIRIA Medical?
Guillaume Petit-Pierre is listed as CEO at ARTIRIA Medical.
Where is ARTIRIA Medical headquartered?
ARTIRIA Medical is based in Lausanne, Vaud, Switzerland.
How many employees does ARTIRIA Medical have?
ARTIRIA Medical is in the 1-10 employee band.
How does ARTIRIA Medical's funding compare to other Biotechnology startups?
ARTIRIA Medical's latest round of $1.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's ARTIRIA Medical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ARTIRIA Medical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.